New hope for Tough-to-Treat liver condition

This study is testing if adding the steroid prednisone to the standard liver disease drug UDCA works better for people with a specific form of primary biliary cholangitis (PBC). It focuses on patients whose liver biopsies show moderate-to-severe inflammation, a group that often doesn't respond well to UDCA alone. The goal is to see if this combination better controls the disease and improves symptoms like itching and fatigue, while monitoring safety.